Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-15-059110
Filing Date
2015-08-12
Accepted
2015-08-12 16:30:58
Documents
14
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a15-12149_110q.htm 10-Q 832802
2 EX-10.2 a15-12149_1ex10d2.htm EX-10.2 121850
3 EX-31.1 a15-12149_1ex31d1.htm EX-31.1 11808
4 EX-31.2 a15-12149_1ex31d2.htm EX-31.2 11870
5 EX-32.1 a15-12149_1ex32d1.htm EX-32.1 9483
12 GRAPHIC g121491ke03i001.jpg GRAPHIC 25021
13 GRAPHIC g121491ke03i002.jpg GRAPHIC 22609
14 GRAPHIC g121491ke03i003.jpg GRAPHIC 36866
  Complete submission text file 0001104659-15-059110.txt   5059692

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT eprs-20150630.xml EX-101.INS 948176
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eprs-20150630.xsd EX-101.SCH 46869
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT eprs-20150630_cal.xml EX-101.CAL 62806
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT eprs-20150630_lab.xml EX-101.LAB 419962
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eprs-20150630_pre.xml EX-101.PRE 317834
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT eprs-20150630_def.xml EX-101.DEF 163767
Mailing Address 699 BOYLSTON ST 8TH FLOOR BOSTON MA 02116
Business Address 699 BOYLSTON ST 8TH FLOOR BOSTON MA 02116 (617) 600-3497
EPIRUS Biopharmaceuticals, Inc. (Filer) CIK: 0001135906 (see all company filings)

EIN.: 043514457 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51171 | Film No.: 151047346
SIC: 2834 Pharmaceutical Preparations